Subunit ε is an intrinsic regulator of the bacterial F o F 1 -ATP synthase, the ubiquitous membrane-embedded enzyme that utilizes a proton motive force in most organisms to synthesize adenosine triphosphate (ATP). The C-terminal domain of ε can extend into the central cavity formed by the α and β subunits, as revealed by the recent X-ray structure of the F 1 portion of the Escherichia coli enzyme. This insertion blocks the rotation of the central γ subunit and, thereby, prevents wasteful ATP hydrolysis. Here we aim to develop an experimental system that can reveal conditions under which ε inhibits the holoenzyme F o F 1 -ATP synthase in vitro. Labeling the C-terminal domain of ε and the γ subunit specifically with two different fluorophores for single-molecule Förster resonance energy transfer (smFRET) allowed monitoring of the conformation of ε in the reconstituted enzyme in real time. New mutants were made for future three-color smFRET experiments to unravel the details of regulatory conformational changes in ε.
INTRODUCTION
To synthesize adenosine triphosphate (ATP) from adenosine diphosphate (ADP) and inorganic phosphate (P i ), the Escherichia coli enzyme F o F 1 -ATP synthase utilizes the electrochemical potential of protons. The bacterial enzyme can also work in reverse and can hydrolyze ATP to pump protons across the membrane [1] . Mechanical rotation of subunits couples proton translocation as the driving force in the F o portion with chemical synthesis or hydrolysis of ATP in the F 1 portion of the enzyme. This mechanism was first proposed by P. Boyer about 30 years ago (reviewed in [2] ). It was demonstrated subsequently by a variety of biochemical [3] [4] [5] [6] [7] and spectroscopic [8] methods as well as single-molecule imaging [9] [10] [11] [12] [13] [14] [15] [16] [17] and single-molecule FRET experiments [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .
The crystal structure of the Escherichia coli F 1 portion was recently resolved at a resolution of 3.26 Å [29, 30] . F 1 consists of five different subunits with stoichiometry α 3 β 3 γδε. The pseudohexagonal arrangement of three pairs of subunits α and β, i.e. α 3 β 3 , forms the main body of F 1 . Each β subunit provides an active nucleotide binding site. The corresponding nucleotide binding sites on the α subunits are catalytically inactive. Subunits α 3 β 3 together with subunit δ at the top of F 1 comprise a non-rotating stator complex [31] . Subunits γ and ε form the central stalk that can rotate within α 3 β 3 and connects to the membrane-embedded ring of 10 c-subunits of the F o portion (Fig. 1A) . The shape of this large enzyme is shown in Fig. 1A as an image reconstruction from electron micrographs [32] . In the F o portion, the a subunit provides two half-channels for proton translocation across the membrane. Two b subunits of F o connect the membrane part as a peripheral stator stalk to the top of F 1 (Fig. 1A) . Thus, the holoenzyme ab 2 c 10 α 3 β 3 γδε can transfer the energy of the transmembrane electrochemical potential of protons via rotational movements of c 10 -ε-γ to the distant nucleotide binding sites in α 3 β 3 where ATP is synthesized. [32] ) in a model lipid bilayer. Overlaid here in ball representation are the subunits that comprise the central rotary stalk: γ (grey) and ε (black) of the recent E. coli F 1 X-ray structure [29] . Subunit a with a C-terminal cysteine mutation (black star) can be labeled for future 3-color FRET experiments. (B) Subunits γ (in grey) and ε (in black, in the 'up' configuration [29] ), showing the positions of two cysteine mutations γ108 and ε99 (highlighted in light grey) for single-molecule FRET. (C) Partial structure of γ (in silver) and ε (in black) from F 1 with ε's C-terminal helices in the 'down'-configuration [33] . Compared to (B), note the distinct distance between cysteines γ108 and ε99 for single-molecule FRET.
The bacterial F o F 1 -ATP synthase is thought to be regulated by conformational changes in subunit ε, a 15 kDa subunit of the F 1 rotor [34] , to control and prevent wasteful ATP hydrolysis in vivo. An E. coli F o F 1 -ATP synthase with a deleted Cterminal domain (CTD) of subunit ε showed not only a higher ATP hydrolysis (ATPase) activity compared to the wild type but also higher ATP synthesis activity [35] . With the CTD of ε in an 'extended' configuration (Fig. 1B) , the enzyme is in an intrinsically inactive state with the γ-ε rotor stalled at a fixed angle [29, 36, 37] . However, ε's CTD can also form a hairpin-folded state [33, 38] with the C-terminal helices in a 'down'-configuration (Fig. 1C) , and the membrane-bound enzyme can catalyze ATP synthesis and hydrolysis with ε trapped in that state [39] . Therefore, a large rearrangement of the C-terminal helices of ε is thought to be a mechanical switch that controls the enzymatic activities of both F 1 -ATPase as well as F o F 1 -ATP synthase.
We developed a single-molecule FRET approach to monitor conformational changes of ε's CTD in purified E. coli F o F 1 -ATP synthase reconstituted in liposomes. Two specifically attached fluorophores were used for smFRET as an internal distance ruler. Based on the E. coli F 1 X-ray structure [29] , we chose residue ε99 on the first C-terminal α-helix of ε, which does not insert into a β-γ cleft in the 'up'-conformation. The second marker position is γ108, yielding distances of about 3 nm or 6 nm to ε99 in the 'up' (Fig. 1B) or 'down' (Fig. 1C) conformations, respectively. These labeling positions were also chosen to avoid perturbing any interactions of ε's CTD (either conformation) with the ε Nterminal domain (NTD) or with the other subunits γ and c. We recorded the dynamics of ε's CTD for several hundred milliseconds using freely diffusing proteoliposomes with single FRET-labeled F o F 1 -ATP synthases.
EXPERIMENTAL PROCEDURES

Preparation of the F 1 portion and the isolated δ and ε subunits
The soluble F 1 portion (F 1 ) of E. coli ATP synthase with an N-terminal 6xHistidine tag (H 6 ) on the β subunits and a specific cysteine substitution in the γ subunit (γK108C) was isolated from membranes and depleted of subunits δ and ε. H 6 -tagged ε subunit was overexpressed separately and contained a unique cysteine mutation εR99C for labeling. The δ subunit was overexpressed separately and purified to complete the F 1 portion. Details of the plasmid constructs used, protein expression and purification procedures are given below.
Plasmid constructs. Plasmid pJW1 [40] was the basis for the construct used to overexpress F o F 1 for purification of F 1 . The H 6 -tag at the N-terminus of β was engineered previously [41] . All native Cys of β and γ subunits were changed to Ala by replacing appropriate restriction fragments of pJW1 with the corresponding regions of a similar plasmid encoding Cysfree F O F 1 [42] . The γK108C mutation (AAA > TGC) was made by site-directed mutagenesis (QuikChange II, Agilent Technologies). Plasmid pH 6 ε [43] was mutated to express H 6 -tagged ε with εR99C (CGT > TGT) and contained no other cysteines. The plasmid pH 6 ε comprises the amino terminal (His6) and a rTEV protease site sequence, MSYYHHHHHH-DYDIPTTENLYFQGA, preceding the atpC open reading frame [43] . Plasmid pJC1 [44] was used for separate expression of the wild-type δ subunit. For all tag sites and mutated regions, DNA sequencing was done to confirm the presence of the expected tag/mutant sequence and the absence of any undesired sequence changes.
Expression of F o F 1 and purification of F 1 (H 6 β/γK108C) depleted of δ and ε subunits. For overexpression of the engineered ATP synthase, pJW1(H 6 β/γK108C) was transformed into an E. coli strain that lacks a chromosomal atp operon (LE392Δ(atpI-C) [45] ). Cells were grown in up to 10 L of defined medium [40] supplemented with 50 mg Met/L, and everted membranes were prepared [40] . Soluble F 1 (H 6 β/γK108C) was released from membranes and purified as described [29] . The ε subunit was depleted from F 1 with an anti-ε immunoaffinity column [46] as described [36] . To remove residual impurities and deplete most δ subunit, F 1 was subjected to immobilized metal affinity chromatography at 4°C. F 1 (H 6 β/γK108C) was diluted in Talon buffer (50 mM Tris-HCl, 40 mM 6-amino n-hexanoic acid, 10%(v/v) glycerol, 5 mM β-mercaptoethanol (βME), 1 mM ATP; pH adjusted to 7.2 at 22°C) and bound to a 10 ml column of Talon resin (Clontech). The column was washed at 2 ml/min with Talon buffer and different additions as follows: 2 volumes of buffer alone, 4 volumes plus 0.2%(w/v) lauryldimethylamineoxide (LDAO) to deplete most of subunit δ, 2 volumes of buffer alone to remove LDAO, and 3 volumes plus 0.1 M imidazole to elute F 1 (H 6 β/γK108C, -δε). The final F 1 (-δε) sample was dialyzed against Talon buffer (with 1 mM DTT instead of βME) to remove imidazole and residual LDAO, then concentrated to >5 mg/ml by ultrafiltration (Vivaspin, 50 kDa MWC) and stored at -80°C.
Expresssion and purification of H 6 -tagged εR99C. His 6 -tagged ε subunit (H 6 εR99C) was expressed in E. coli strain BL21Star(DE3) (Life Technologies). Cell growth and induction by IPTG were done as described [43] . The H 6 εR99C subunit was purified essentially as described for H 6 ε [36] but buffers for Talon chromatography contained 1 mM βME, whereas buffers for gel filtration and storage contained 1 mM DTT.
Expresssion and purification of subunit δ. Plasmid pJC1 was transformed into strain LE392Δ(atpI-C). Cells were grown at 30°C in 2 Liters of LB broth plus 1 mM MgSO 4 , 1%(v/v) glycerol, and ampicillin (0.1 mg/ml). Expression of δ was induced with IPTG and isolation of δ was done as described [44] , through the step of anion exchange chromatography (BioRad, Macro-Prep DEAE resin, 10 ml column). This partially pure δ was concentrated and exchanged into 'TED' buffer (20 mM Tris-HCl, 1mM EDTA, 1 mM DTT, pH 8.0) with 0.2 M Na 2 SO 4 and subjected to hydrophobic interaction chromatography at 4°C. The δ sample was applied to a 10 ml column of Macro-Prep t-butyl resin (BioRad), and a flow rate of 1 ml/min was used. The column was washed with 3 volumes of TED+0.2 M Na 2 SO 4 and δ (>95% pure) eluted immediately. Importantly, this eliminated residual amounts of a ~14 kDa proteolytic fragment of δ that is often present [44] . For the final δ sample, ultrafiltration (Vivaspin, 10K MWCO) was used to reduce Na 2 SO 4 to ~10 mM and concentrate δ to >15 mg/ml for storage at -80°C.
Labeling of F 1 (H 6
/γK108C) with Atto488-maleimide and H 6 εR99C with Atto647N-maleimide.
The γ subunit of F 1 with the mutation K108C was labeled with Atto488-maleimide as described [47, 48] . Fluorescence labeling of 13 µM F 1 resulted in a labeling ratio of 0.55 for the γ subunit according to quantitative SDS-PAGE analysis using a Typhoon scanner. In addition, cysteines of the residual δ subunit were partly labeled with Atto488. F 1 -Atto488 was flash-frozen in liquid N 2 and stored at -80° C in MTKE7 buffer (20 mM MOPS-Tris, 50 mM KCl, 0.1 mM EDTA, pH 7.0) with 10% glycerol and 1 mM ATP. His 6 -tagged ε subunit with the mutation R99C was labeled with Atto647N-maleimide. 50.1 µM ε contained 17.4 µM Atto647N yielding a labeling ratio of 0.30. ε-Atto647N was flash-frozen in liquid N 2 and stored in MTKE7 buffer with 10% glycerol at -80° C.
Preparation of E. coli F o F 1 and F o -proteoliposomes
E. coli strain and growth conditions. Plasmid constructs were based on plasmid pRA100 which carries the atp operon (without atpI) [49] . For expression of these atp genes, the strain RA1 (F -thi rpsL gal Δ(cyoABCDE)456::KAN Δ(atpBatpC) ilv:Tn10) [50] was used lacking a functional F o F 1 -ATP synthase. Cells were grown in a modified complex medium (0.5 g/l yeast extract, 1 g/l tryptone, 17 mM NaCl, 10 mM glucose, 107 mM KH 2 PO 4 , 71 mM KOH, 15 mM (NH 4 ) 2 SO 4 , 4 μM uracil, 50 μM H 3 BO 3 , 1 μM CoCl 2 , 1μM MnCl 2 , 2 μM ZnCl 2 , 10 μM CaCl 2 , 3 μM FeCl 2 , 0.5 mM MgSO 4 , 0.5 mM arginine, 0.5 mM isoleucine, 0.7 mM valine, 4 μM thiamine and 0.4 μM 2,3-dihydroxybenzoic acid) in a 10 L fermenter (FerMac 320, Electrolab, UK). Growth conditions were as follows: 37°C, 800 rpm stirring, aerated with 4.5 L/min, harvested at the middle-late logarithmic phase (OD 600nm = 0.8). Cells were collected by centrifugation in a Sorvall Evolution RC centrifuge (Thermo Fisher Scientific, USA) at 10,000 × g and 4° C for 5 min, washed with 50 mM Tris-HCl pH 8.0, and collected as described. Cells were then flash-frozen in liquid nitrogen and stored at -80°C.
Purification of E. coli F o F 1 . F o F 1 was purified by a combination of two published methods. Membranes were isolated and washed using a modified protocol [51] followed by a modified solubilization and further purification as described [52] . Briefly, approximately 30 g frozen cells were thawed in a water bath and resuspended in 200 ml buffer A containing 50 mM MOPS-KOH pH 7.0, 175 mM KCl, 10 mM MgCl 2 , 0.2 mM EGTA, 0.2 mM DTT and 0.1 mM PMSF. Unless otherwise noted, all subsequent steps were done at 4°C. One spatula point of DNase I and RNase A were added directly before cell lysis by two passages through a precooled PandaPlus 2000 cell homogenizer (GEA Niro Soavi, Italy) at 1000 bar. Between the two passages, the cells were kept on ice. After removal of cell debris by two centrifugations at 25,000 × g for 20 min in a Sorvall Evolution RC centrifuge (Thermo Fisher Scientific, USA), membranes were collected by centrifugation at 300,000 × g for 2 h in an Optima XP ultracentrifuge (Beckman Coulter, USA) using a type 70 Ti rotor. The membrane pellet was resuspended in 150 ml buffer B containing 5 mM Tris-HCl pH 8.0, 5 mM MgCl 2 , 0.2 mM EGTA, 0.2 mM DTT, 6 mM p-amino-benzamidine (PAB), 10%(v/v) glycerol and 0.1 mM PMSF using a soft paintbrush and centrifuged for 1.5 h at 300,000 × g. This washing step was repeated using 100 ml buffer B. The pellet was homogenized in 20 mM MES/Tricine-KOH pH 7.0, 5 mM MgCl 2 , 2 mM DTT and 0.001% (w/v) PMSF and adjusted to 10 ml buffer per g membrane protein. F o F 1 was solubilized by dropwise addition of dodecylmaltoside (DDM; Glycon, Germany; 15% (w/v) stock solution) to 1.75% (w/v) final, then incubating for 2 h on ice with gentle stirring. Unsolubilized membranes were then pelleted by centrifugation at 300,000 × g for 1.5 h. Ammonium sulfate was added in two steps to the supernatant. Impurities were precipitated first with 45% (w/v) saturated (NH 4 ) 2 SO 4 and separated by centrifugation (35,000 x g, 15 min). Then, F o F 1 was precipitated with 65% (w/v) saturated (NH 4 ) 2 SO 4 and pelleted in the same way.
The protein pellet was dissolved in 2.5 ml of size exclusion buffer (SEC-buffer) containing 40 mM MOPS-KOH pH 7.5, 80 mM KCL, 4 mM MgCl 2 , 2 mM DTT, 2% (w/v) sucrose, 10% (v/v) glycerol, 1% (w/v) DDM and 0.001% (w/v) PMSF. To separate the protein from residual (NH 4 ) 2 SO 4 , lipids and nucleotides, the solution was applied to a selfpacked XK16/100 Sephacryl S300 size exclusion column connected to an Äkta PrimePlus FPLC (GE-Healthcare, USA) and equilibrated with SEC-buffer containing 0.1% (w/v) DDM. The protein was eluted at a flow rate of 0.6 ml/min and fractions of 4 ml were collected. The peak fractions were pooled to 8 ml fractions and were loaded separately on a Poros HQ 20 (4.6 x 100 mm) ion exchange column (Applied Biosystems, USA) connected to a modular FPLC system (LCC500 controller, P500 pumps, Frac100 fractionator, UVM II UV monitor) (Pharmacia, Sweden) and equilibrated with the SEC-buffer. After washing the column with 5 column volumes of SEC-buffer, F o F 1 was eluted by a KCL gradient over 20 column volumes up to 0.75 M KCl and collected in 1 ml fractions. The protein of the pooled main peak fractions was precipitated with 65% (v/v) saturated (NH 4 ) 2 SO 4 and pelleted by centrifugation (35,000 × g, 15 min). The protein pellet was then resolved in 0.5 ml SEC-buffer. To separate the F o F 1 from residual salt and minor impurities, the sample was applied to a second size exclusion step using a self-packed XK16/100 Sephacryl S400 column (GEHealthcare, USA) and the buffers and specifications listed above. The peak fractions were directly tested for ATPase activity, pooled and shock-frozen in liquid nitrogen in 500 µl cryo straws and stored at -80°C.
Reconstitution. F o F 1 was reconstituted into preformed liposomes as described [53] at a concentration of 20 nM F o F 1 . Given a lipid concentration of 8 g/l and a mean liposome diameter of 120±10 nm, a ratio of four liposomes per F o F 1 ensured proteoliposomes with only a single enzyme [18] . Briefly, 2.5 µl of a 1 M MgCl 2 solution, 500 µl of preformed liposomes [54] and 10.6 µg of purified protein were diluted with liposome buffer (20 mM Tricine-NaOH pH 8.0, 20 mM succinate, 80 mM NaCl and 0.6 mM KCl) to a volume of 920 µl. Immediately, 80 µl of a 10% (v/v) Triton X-100 solution were added under vigorous stirring to destabilize the liposomes. After 1 h incubation under slow shaking (2 rpm, 45° angle) 520 mg of BioBeads SM-2 (Biorad, USA), pretreated according to [55] , were added to remove the detergent. After an additional hour of shaking, the proteoliposomes were separated from the BioBeads and immediately used for stripping off the F 1 portion of the enzyme.
Stripping of F 1 . F o -liposomes were prepared by stripping the F 1 portion (modified from [56] ). 1 ml F o F 1 -liposomes were diluted with 24 ml of stripping buffer (1 mM Tricine-NaOH pH 8.0, 1 mM DTT, 0.5 mM EDTA, and 4% (v/v) glycerol) in a type 70 Ti centrifuge tube (Beckman Coulter, USA), incubated for 1 h at room temperature under slow rotation (5 rpm), and centrifuged at 300,000 × g for 1,5 h at room temperature. The pellet was resuspended twice in 25 ml of stripping buffer followed by incubation and centrifugation under the same conditions. Finally, the stripped F oliposomes were resuspended in stripping buffer with 10% glycerol to yield an F o concentration of 125-150 nM, flashfrozen in 10 µl aliquots in liquid nitrogen and stored at -80°C.
Other methods. Protein concentrations were determined either by UV absorption or by the amido black method [57] . SDS-polyacrylamide gels were made according to [58] with a 12% separating gel and either stained by silver [59] or coomassie R-250 [60] .
Preparation of proteoliposomes with a single F o F 1 -γ108-atto488/ε99-atto647N
Rebinding of FRET-labeled F 1 to F o -proteoliposomes. Atto488-labeled F 1 (-δε) (see above) was reassembled with Atto647N-labeled ε in a first step and subsequently rebound to Fo-liposomes in two steps. First, 4 µM Atto647N-labeled ε was bound to 3 µM of Atto488-labeled F 1 (-δε) by incubation in liposome buffer for 30 min at room temperature yielding FRET-labeled F 1 (-δ). A fivefold excess of the purified δ subunit was added to complement F 1 . FRET-labeled F 1 in solution was incubated with the F o -liposome suspension at a molar excess of three F 1 per F o in the presence of 2.5 mM MgCl 2 and 50 mM NaCl, first for 45 min at 37°C and then for 90 min at 0°C. Excess, unbound F 1 and δ were removed by three ultracentrifugations (90 min, 300,000 × g, 4°C), each time resuspending the pellet in buffer (20 mM Tricine-NaOH (pH 8.0), 20 mM succinic acid, 50 mM NaCl, 0.6 mM KCl, 2.5 mM MgCl 2 and 4% (v/v) glycerol). The final concentration of F o F 1 in proteoliposomes was adjusted to ~100 nM. Proteoliposomes were either used directly for smFRET measurements, or adjusted to 10% (v/v) glycerol, flash-frozen as 10 µl aliquots in liquid nitrogen and stored at -80°C.
Confocal single-molecule FRET microscope
Custom-designed confocal microscope for smFRET. The setup has been described previously [61, 62] . Briefly, a solid-state continuous-wave laser (Cobolt Calypso, 50 mW) was used for excitation with 491 nm. The laser beam was deflected by the two crystals of a pair of acousto-optical beam deflectors (AOBD 46080-3-LTD, NEOS technologies, Gooch & Housego). The diffracted first order beam was selected by an aperture. The beam diameter was diminished by two lenses (f 1 = 200 mm, f 2 = 100 mm) before entering the back aperture of an oil immersion microscope objective (PlanApo 100x, N.A. 1.35, Olympus). A dichroic beam splitter (488 RDC, AHF Tübingen, Germany) rejected scattered laser light from fluorescence photons in the detection pathway. An achromatic lens (200 mm) imaged the confocal excitation volume onto the center of the pinhole (150 µm) which was mapped on to the detection area of two single photoncounting avalanche photodiodes (SPAD, SPCM-AQR-14, Perkin-Elmer) by additional lenses (50 mm). Fluorescence was separated into two channels for FRET measurements by a beam splitter 575DCXR (AHF Tübingen). FRET donor fluorescence was detected after an additional band pass filter ET535/70M (AHF Tübingen), and FRET acceptor fluorescence was detected after a long pass filter HQ 595 LP (AHF Tübingen). Arrival times of photons were recorded with TCSPC electronics (16 channel photon correlator DPC230, Becker&Hickl, Berlin, Germany). However, the picosecond time resolution of the TCSPC card was not required for the measurements of binned fluorescence intensity only. Data analysis was performed with the software 'Burst Analyzer' (version 2.0, Becker&Hickl, Berlin, Germany).
Single-molecule FRET experiments were carried out in liposome buffer (20 mM succinic acid, 20 mM tricine, 80 mM NaCl, 0.6 mM KCl, 2.5 mM MgCl 2 , adjusted pH to 8.0 with NaOH). Proteoliposome aliquots were used within 24 h after thawing.
To study the conformations of the C-terminal helices of the ε subunit in F o F 1 -ATP synthase by single-molecule FRET, we first attached the two FRET fluorophores specifically to the F 1 portion and then reassembled the holoenzyme by binding F 1 to F o in liposomes in the presence of subunit δ. Cysteine 108C of the γ subunit in (ε-and δ-depleted) F 1 was labeled with Atto488 with a labeling efficiency of 55%. The ε subunit was purified separately, and cysteine residue ε99C was labeled with Atto647N-maleimide as FRET acceptor with 30% efficiency as described above (and elsewhere [47] ). Mixing F 1 (3 µM) with ε (4 µM) yielded FRET-labeled F 1 , due to ε's high binding affinity (K D~ 0.3 nM [36] ). In the presence of a fivefold excess of purified δ, labeled F 1 was reassembled with non-labeled F o in liposomes to yield the holoenzyme F o F 1 -ATP synthase as described above and according to published procedures [18] . Figure 2 . Lanes 1 to 6: SDS-PAGE of labeled F 1 -γ108-atto488 and His 6 ε99-atto647N (12% PA gel according to Schaegger and von Jagow [58] , with Coomassie blue staining of F 1 -ATPase subunits in lanes 2 to 4, and fluorescence images in lanes 5 and 6. Lane 1 is the molecular weight standard. Lane 2 shows F 1 -γ108-atto488. Atto488-maleimide labeling resulted in an additional labeling of cysteines of residual δ subunit (lane 5). Lane 3, ε99-atto647N preparation showing two fluorescence-labeled products ε* and ε** (lane 6, for details see text). Lanes 7 and 8: SDS-PAGE of labeled F o F 1 -a-C-Term- cys. Lane 7 shows Coomassie blue-stained subunits of F o F 1 -ATP synthase, lane 8 specific Alexa488-maleimide labeling of the cys residue introduced to the C-terminus of subunit a (for details see text). Figure 2 shows the different protein preparations as separated subunits on SDS-PAGE, either as fluorescence images after labeling or subsequent staining with Coomassie blue. F 1 -(δ,ε) was mainly labeled on γ108 (lane 5), with minor labeling of residual δ that contained the two native cysteines. Labeling ε yielded two fluorescent products ε* and ε** (lane 6). Because ε contained a H 6 -tag for purification and an additional TEV cleavage site, the bright ε* band likely represents the Atto647N-labeled, full-length tagged subunit, and ε** a small fraction of labeled ε that has been proteolyzed at 1 or more undetermined sites. Using SDS-PAGE according to Schaegger and von Jagow [58] showed separate bands for Atto647N-labeled and unlabeled ε subunit (bands below ε* or ε** in lane 3). This is likely due to the additional molecular weight (770 Da), additional positive charge and the hydrophobicity of the dye. On Laemmli-type gels [63] (not shown) only two prominent bands were seen, and both showed the Atto647N labeling. Similarly, the Alexa488-labeled a subunit with a cysteine added to the C-terminus (a-GAAACA) in F o F 1 -ATP synthase was separated as a' from unlabeled a in SDS-PAGE according to Schaegger and von Jagow (lanes 7, 8 in Fig. 2 ). We used F 1 -(δ,ε) and ε without further purifications for generating the reconstituted FRET-labeled holoenzyme F o F 1 -ATP synthase.
Single-molecule FRET time trajectories were recorded with a custom-designed confocal microscope using 491 nm continuous-wave excitation (260 µW at the back aperture of the objective). The mean observation time of freely diffusing F o F 1 -ATP synthase in liposomes with ~120 nm diameter was 30 to 70 ms, compared to a diffusion time t D~4 10 µs for rhodamine 110 in water (FCS data not shown). Maximum photon counts for single rhodamine 110 molecules in 1-ms-binned time traces were ~80 kHz, or 80 counts per ms, respectively. Accordingly the upper limit to assign a single FRET-labeled F o F 1 ATP synthase in a liposome was set to 100 counts/ms for further analysis. A broad distribution of constant proximity factor values was found. In Fig. 3A , the observation time of the photon burst was 120 ms with P~0.12. In Fig. 3B the burst duration was 131 ms with P~0.17, and in Fig. 3C the burst was observed for 83 ms with P~0.35. Higher FRET efficiencies were found as well: in Fig. 3D with P~0.56 (68 ms duration), in Fig.  3E with P~0.59 (339 ms) and in Fig. 3F with P~0.74 (38 ms). For each example, standard deviation for the P value was in the range of ~0.1.
However, we also observed photon bursts with fluctuating, stepwise switching proximity factors and oligomers of FRET-labeled enzyme in liposomes as shown in Fig. 4 . Some bursts were characterized by P ~0.9 to 1 with no detectable FRET donor signal ( Fig. 4A; burst duration 202 ms) , which we interpreted as likely artifacts. In Fig. 4B , in a photon burst with 110 ms duration, stepwise FRET changes occurred from P~0.60 (for 49 ms) to P~0.41 (50 ms) with manual assignment of apparently constant FRET levels. The photon burst with 85 ms duration in Fig. 4C switched from P~0.28 (62 ms) to P~0.63 (18 ms), and another in Fig. 4D from P~0.41 (29 ms) to P~0.80 (61 ms) during an observation time of 102 ms. The 109 ms long photon burst in Fig. 4E showed multiple changes, from P~0.47 (23 ms) to P~0.13 (15 ms) to P~0.71 (4 ms) and to P~0.77 (10 ms) after an intermediary, brief low-FRET period. All photon bursts were characterized by photon count rates of less than 100 counts per ms for FRET donor plus FRET acceptor. Therefore, the few bursts with intensities exceeding 500 counts per ms, as shown in Fig. 4F , clearly originated from multiple FRET-labeled F o F 1 -ATP synthases in single liposomes. These multimers were rarely detected and were eliminated from further analysis.
Next we recorded single-molecule FRET of F o F 1 -ATP synthase in the presence of 1 mM MgATP. Only a few longlasting photon bursts exhibited a single constant FRET level; most F o F 1 -ATP synthases showed transitions in FRET efficiencies as shown in Fig. 5 . The photon burst in Fig. 5A with 308 ms duration switched from initial P~0.68 (15 ms) to P~0.20 (63 ms), followed by a low intensity period of burst, then switched to P~0.18 (29 ms) and to P~0.86 (37 ms) before leaving the detection volume with P~0.27 (12 ms). The second example in Fig. 5B (221 ms) began with P~0.62 for 90 ms, switched to P~0.31 (20 ms) and then to P~0.81 (34 ms). In Fig. 5C , the 167 ms long photon bursts started at P~0.50 (28 ms), changed to P~0.24 (41 ms), then to P~0.59 (16 ms) and finally to P~0.22 (39 ms). The enzyme in Fig. 5D switched from P~0.75 (5 ms) to P~0.43 (7 ms) in a short 37 ms burst, and the enzyme in Fig. 5E changed proximity factors from P~0.42 (13 ms) to P~0.26 (46 ms) during a 138 ms observation time. Fig. 5F shows a photon burst with 197 ms duration, that apparently changed from P~0.17 to P~0.58 but with a maximum intensity of 170 counts per ms, indicating this was probably not a single FRET-labeled F o F 1 -ATP synthase.
To compare the conformational states and changes of the C-terminal part of ε in the holoenzyme, we plotted the manually-assigned FRET levels (proximity factors P) for both biochemical conditions in Fig. 6 . In the absence of added nucleotides we found two broad maxima in the P histogram of 231 states in Fig. 6A . The low-FRET fraction with 0<P<0.3 will likely contain a few Atto488-only-labeled F o F 1 -ATP synthases (FRET donor only) including some enzymes that had the residual δ subunit labeled with Atto488. The second population (0.4<P<0.8) with maximum at P~0.65 could represent enzymes with ε in the 'up' conformation. In contrast, the proximity factor distribution in the presence of 1 mM MgATP (Fig. 6B) showed three distinguishable populations for the 128 states: one with FRET levels 0<P<0.3 as before, a second population with P values shifted to lower FRET efficiencies (0.35<P<0.6), and a third population with high FRET levels (0.7<P<0.9). The number of FRET levels in these two populations with P>0.3 seemed to be similar, but with a slightly higher occurrence of the lower FRET levels. 
DISCUSSION
Monitoring conformational changes within single reconstituted F o F 1 -ATP synthase required an in vitro assembly process using specifically labeled subunits and protein portions of this membrane enzyme from E. coli. Assembly procedures had been developed previously for single-molecule FRET measurements of subunit rotation in reconstituted F o F 1 -ATP synthase in buffer solution [18-23, 27, 28] . Binding constants for individual subunits as well as F 1 to F o assembly are in the 1-nM range or below [36, [64] [65] [66] [67] [68] . First we purified the F 1 -γ108C portion for labeling with Atto488. This F 1 was depleted of δ and ε subunits. Separately we purified a cysteine mutant of the ε subunit, ε99C, for labeling with Atto647N. F 1 -γ108-atto488 and ε99-atto647N were combined to yield F 1 -γ108-atto488/ε99-atto647N as described previously [47] (see also S. D. Bockenhauer et al. [69] , preprint available at http://arxiv.org/abs/1402.1845). To complete F 1 with all 9 subunits, we added an excess of additional δ that was overexpressed [44] and purified separately. The FRETlabeled F o F 1 -ATP synthase was obtained by rebinding F 1 to the non-labeled F o portion that was reconstituted in liposomes stochastically with less than one F o per vesicle. Successful assembly of the holoenzyme was proven by fluorescence correlation spectroscopy showing diffusion times for the FRET-labeled proteoliposomes in the range of 30 to 70 ms, i.e. ~100 times longer than a single rhodamine 110 molecule in buffer.
We analyzed the conformation of ε's C-terminal helices in F o F 1 -ATP synthase by confocal single-molecule FRET using a custom-designed basic microscope with two SPAD detectors [18, 61, 70] . However, to reveal the simultaneous attachment of both FRET donor and acceptor fluorophores on the individual enzyme, a more sophisticated laser excitation scheme with two alternating wavelengths is recommended. We have established such a confocal setup for duty cycle-optimized alternating laser excitation (DCO-ALEX [71] [72] [73] [74] [75] [76] ) using pulsed lasers but could not use this microscope for our measurements here. Therefore, low FRET efficiencies of photon bursts with proximity factors 0<P<0.2 might result from FRET donor-only labeled enzymes and should be omitted from further analysis. Very high FRET efficiencies in photon bursts as shown in Fig. 4A should be confirmed using the second pulsed laser in DCO-ALEX (at 635 nm) and fluorescence lifetime analysis of the FRET acceptor. Furthermore, single-molecule fluorescence anisotropies of FRET donor and acceptor in the local protein environments on γ and ε should be determined to ensure a reasonably high flexibility of the attached dyes to justify the assumption of κ 2 =2/3 according to the Förster theory of FRET [77] .
Single-molecule FRET measurements would benefit from longer observation times of individual enzymes. One elegant device to hold single proteoliposomes in solution is the anti-Brownian electrokinetic (ABEL) trap invented by A. E. Cohen and W. E. Moerner [78, 79] . Microfluidics confine diffusion to two dimensions, fluorescence is used to identify the position of the labeled molecule in real time, and a fast feedback [80] in µs pushes the object back to the center of confocal imaging using electric potentials generated with platinum electrodes. We have recently used the ABEL trap to analyze ε's CTD in single FRET-labeled F 1 -γ108-atto488/ε99-atto647N in solution [69] . Constant fluorescence intensities of ABEL-trapped F 1 could be used to eliminate aggregates and other artifacts in the data set from further analysis. Due to long observation times of hundreds of ms (instead of only 2 to 5 ms for F 1 freely diffusing through the detection volume) we could identify FRET levels and fluctuations in the absence and presence of added MgATP and MgAMPPNP. This approach could also be used for the proteoliposomes measured here, and would improve the detection of fluctuating FRET levels. Furthermore, ambiguities due to manual assignment of FRET levels in the time traces and small smFRET data sets (sufficient for our proof-of-principle study here) have to be solved, for example, using automatic data analysis tools like Hidden Markov Models (HMM) [75, 81] . Finally, we want to improve the smFRET detection of ε's CTD conformational changes in single F o F 1 -ATP synthase by discrimination of rotating, active enzymes and ε-inhibited F o F 1 . Using the C-terminal cysteine mutant for specifically labeling subunit a in F o (as shown in Fig. 2) we will be able to simultaneously measure rotation of subunit γ and ε by smFRET to a as well as the conformation of ε's CTD by alternating lasers in nanoseconds for smFRET between γ108 and ε99. Similar to our first implementation of 3-color smFRET experiments [23] to monitor ε rotation and elastic twisting of the γ-ε-c rotor portion in single F o F 1 -ATP synthase [28, 82, 83] , we aim at maximizing the obtainable information about intramolecular distance fluctuations within single enzymes one-at-a-time.
Despite the technical factors noted above, the preliminary smFRET results presented here indicate significant potential for further understanding the dynamic conformational changes of ε's CTD and how these correlate with function control of the intact bacterial ATP synthase. The results are especially interesting in comparison with our initial smFRET results with isolated F 1 that used the same labeled donor/acceptor pair, γ108C/ε99C [47] . First, the slower diffusion of F o F 1 -liposomes here allowed longer observation times and we were able to observe transitions between FRET states, especially upon addition of substrate MgATP; more extensive data sets should allow us to characterize the kinetics of ε's conformational changes under different functional conditions (e.g., ATP synthesis vs hydrolysis). Second, without added nucleotide, soluble F 1 /ε showed a FRET distribution predominated by one main peak at ~0.6 P, whereas F o F 1 -liposomes in this study showed a distinct, bimodal distribution between low-and high-FRET states (Fig. 6) . This difference is expected from functional studies, since >90% of soluble F 1 /ε complexes are in the ε-inhibited state [34, 36] , whereas ATPase of F o F 1 appears to be only ~50% inhibited by the ε CTD [35, 39] . Third, with MgATP added, soluble F 1 /ε showed a bimodal FRET distribution but a trimodal distribution is observed here with F o F 1 -liposomes. This could indicate that association of F 1 with F o alters the kinetically significant intermediate states/positions of ε's CTD. This is not unexpected, since functional [36] and rotary-bead studies [37, 84] indicate that the ε CTD inserts into F 1 's central cavity at the catalytic dwell (+80° rotary angle), whereas the structure of ε-inhibited E. coli F 1 appears to be stopped after the next rotary sub-step (+120° rotary angle). Also, the transition from ε's 'down' state toward the 'up' state may involve an intermediate with a highly mobile CTD, which would likely put ε99C more distant from γ108C (on average), and could account for some of the lowest FRET levels observed here. Our future experiments with 3-color smFRET, including a probe on subunit a of F o , should help further correlate these putative states of ε's CTD with functional and rotational states of the F o F 1 -ATP synthase.
